Journal
NUCLEIC ACIDS RESEARCH
Volume 42, Issue 4, Pages 2197-2207Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkt1216
Keywords
-
Categories
Funding
- Institut National du Cancer (INCa)
- Agence Nationale de la Recherche (ANR)
- Fondation Recherche Medicale (FRM)
- Ligue Nationale Contre le Cancer
- Association Francaise contre les Myopathies
- FRM
- Association pour la Recherche sur le Cancer
- Ligue Nationale Contre le Cancer (LNCC)
- Association Francaise contre les Myopathies (AFM)
- Association pour la Recherche sur le Cancer (ARC)
Ask authors/readers for more resources
Estrogen and androgen receptors (ER and AR) play key roles in breast and prostate cancers, respectively, where they regulate the transcription of large arrays of genes. The activities of ER and AR are controlled by large networks of protein kinases and transcriptional coregulators, including Ddx5 and its highly related paralog Ddx17. The Ddx5 and Ddx17 RNA helicases are also splicing regulators. Here, we report that Ddx5 and Ddx17 are master regulators of the estrogen- and androgen-signaling pathways by controlling transcription and splicing both upstream and downstream of the receptors. First, Ddx5 and Ddx17 are required downstream of ER and AR for the transcriptional and splicing regulation of a large number of steroid hormone target genes. Second, Ddx5 and Ddx17 act upstream of ER and AR by controlling the expression, at the splicing level, of several key regulators of ER and AR activities. Of particular interest, we demonstrate that Ddx5 and Ddx17 control alternative splicing of the GSK3 beta kinase, which impacts on both ER and AR protein stability. We also provide a freely available online resource which gives information regarding splicing variants of genes involved in the estrogenand androgen-signaling pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available